Abstract

Matrix metalloproteinase 2 (MMP-2) in metastatic cancer tissue, which is associated with a poor prognosis, is a potential target for tumor imaging in vivo. Here, we describe a metastatic cancer cell-targeted protein nanocage. An MMP-2-binding peptide, termed CTT peptide (CTTHWGFTLC), was conjugated to the surface of a naturally occurring heat shock protein nanocage by genetic modification. The engineered protein nanocages showed a binding affinity for MMP-2 and selective uptake in cancer cells that highly expressed MMP-2 in vitro. In near-infrared fluorescence imaging, the nanocages showed specific and significant accumulation in tumor tissue after intravenous injection in vivo. These protein nanocages conjugated with CTT peptide could be potentially applied to a noninvasive near-infrared fluorescence detection method for imaging gelatinase activity in metastatic tumors in vivo.

Highlights

  • Tumor invasion and metastasis define malignancy, which are the major causes of cancer mortality.Metastasis is a complex multi-step process involving detachment of tumor cells from the primary tumor, invasion through the basement membrane, intravasation into the circulatory system, extravasation at a distant site, and outgrowth of a secondary tumor [1]

  • We focused on development of a metastatic tumor imaging techniques using nanoparticles that target Matrix metalloproteinase 2 (MMP-2) in cancer cells

  • Characterization of the Protein Nanocages Modified with CTT Peptides

Read more

Summary

Introduction

Tumor invasion and metastasis define malignancy, which are the major causes of cancer mortality. MMP-2 is a potential target for metastatic tumor imaging. Positron emission tomography of MMP-2 has been performed in a metastatic tumor model in vivo using 64Cu-DOTA-CTT [12]. We focused on development of a metastatic tumor imaging techniques using nanoparticles that target MMP-2 in cancer cells. These nanoparticles were developed by a genetic engineering approach involving the addition of CTT peptides to the exterior surface of the nanoparticle. We determined the physical properties, MMP-2-binding capacity, cytotoxicity, and cellular uptake of CTT peptide-conjugated protein nanocages, and applied them as an NIR fluorescence contrast agent to detect tumor cells in vivo

Characterization of the Protein Nanocages Modified with CTT Peptides
Cellular Uptake of the Protein Nanocages in Vitro
Biodistribution of the Protein Nanocages in Vivo
Protein Expression
Protein Purification
Size Measurements
MMP-Binding Assay
Conjugation of Fluorophores to Protein Nanocages
Cell Study
Biodistribution in Vivo
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call